MedPath

A STUDY TO EVALUATE INCIDENCE OF RADIATION INDUCED PNEUMONITIS IN LUNG CANCER

Not Applicable
Completed
Conditions
Health Condition 1: null- PATIENTS HAVING LUNG CANCER SHALL BE ACCRUED AFTER COMPLETION OF (CHEMO)RADIOTHERAPY
Registration Number
CTRI/2012/08/002870
Lead Sponsor
TATA MEMORIAL HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
68
Inclusion Criteria

1)All patients of lung cancer treated with curative doses of Radiotherapy/Chemo-radiotherapy.

2) Patients who are willing to participate in the study.

Exclusion Criteria

1)Patients who have received reirradiation to lung.

2)All patients for palliative radiotherapy doses.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Appearance of symptoms of radiation pneumonitis (grade 2 or more) in radically treated lung cancer patients. <br/ ><br>Timepoint: At every three monthly follow up for a period of one year
Secondary Outcome Measures
NameTimeMethod
Appearance of radiological changes of RIP within a time interval of one year and their correlation with the dose distribution as well as the various factors modifying them.Timepoint: At every three monthly follow up for a period of one year
© Copyright 2025. All Rights Reserved by MedPath